Pharmaceuticals Retinal Disorder Treatment Market F...

Retinal Disorder Treatment Market Forecast to 2027 - Covid-19 Impact and Global Analysis - By Product Type (Gels, Eye Solutions, Capsules and Tablets, Eye drops, Ointments) ; Disease Indication (Diabetic Retinopathy, Macular Degeneration, Diabetic Macular Edema, Retinal Vein Occlusion, Others) ; Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) and Geography

Report Code: TIPRE00006833 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Retinal diseases are caused due to diabetes, aging, trauma to the eye, or family history. The main aim of treatment procedures is to slow or stop the disease progression and preserve, improve or restore patient's vision. Various treatments are used to treat retinal disorders like injecting medicine into the eye, retinal prosthesis, gels, eye drops

MARKET DYNAMICS

The retinal disorder treatment market is anticipated to grow in the forecast, owing increasing investments in retinal disorder research, growing prevalence of retinal disorders and increasing geriatric population. In addition, presence of strong pipeline products in order to treat retinal disorders are expected to offer significant growth opportunities in the market during the forecast period.

MARKET SCOPE

The "Retinal Disorder Treatment Market Analysis to 2027" is a specialized and in-depth study of the pharmaceutical industry with a special focus on the global market trend analysis. The report aims to provide an overview of retinal disorder treatment market with detailed market segmentation by product type, disease indication, distribution channel, and geography. The retinal disorder treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading retinal disorder treatment market players and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The retinal disorder treatment market is segmented on the basis of product type, disease indication and distribution channel. Based on product type the market is segmented as gels, eye solutions, capsules and tablets, eye drops, ointments. On the basis of disease indication the market is segmented into diabetic retinopathy, macular degeneration, diabetic macular edema, retinal vein occlusion and others. Based on distribution channel, the retinal disorder treatment market is segmented into hospital pharmacy, online pharmacy and retail pharmacy.



Get more information on this report :

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the retinal disorder treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The retinal disorder treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting retinal disorder treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the retinal disorder treatment market in these regions.



Get more information on this report :

MARKET PLAYERS

The report covers key developments in the retinal disorder treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from retinal disorder treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for retinal disorder treatment market in the global market. Below mentioned is the list of few companies engaged in the retinal disorder treatment market.

The report also includes the profiles of key retinal disorder treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •  NOVARTIS AG
  •  SANTEN PHARMACEUTICAL CO., LTD.
  •  REGENERON
  •  GRAYBUG VISION, INC
  •  SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
  •  BAYER AG
  •  GENENTECH, INC.
  •  ACUCELA INC
  •  PFIZER, INC
  •  OXURION NV
The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Retinal Disorder Treatment Market - By Product Type
1.3.2 Retinal Disorder Treatment Market - By Disease Indication
1.3.3 Retinal Disorder Treatment Market - By Distribution Channel
1.3.4 Retinal Disorder Treatment Market - By Region
1.3.4.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. RETINAL DISORDER TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS

5. RETINAL DISORDER TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC

6. RETINAL DISORDER TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. RETINAL DISORDER TREATMENT - GLOBAL MARKET OVERVIEW
6.2. RETINAL DISORDER TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. RETINAL DISORDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT TYPE
7.1. OVERVIEW
7.2. PRODUCT TYPE MARKET FORECASTS AND ANALYSIS
7.3. GELS
7.3.1. Overview
7.3.2. Gels Market Forecast and Analysis
7.4. EYE SOLUTIONS
7.4.1. Overview
7.4.2. Eye Solutions Market Forecast and Analysis
7.5. CAPSULES AND TABLETS
7.5.1. Overview
7.5.2. Capsules and Tablets Market Forecast and Analysis
7.6. EYE DROPS
7.6.1. Overview
7.6.2. Eye drops Market Forecast and Analysis
7.7. OINTMENTS
7.7.1. Overview
7.7.2. Ointments Market Forecast and Analysis

8. RETINAL DISORDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISEASE INDICATION
8.1. OVERVIEW
8.2. DISEASE INDICATION MARKET FORECASTS AND ANALYSIS
8.3. DIABETIC RETINOPATHY
8.3.1. Overview
8.3.2. Diabetic Retinopathy Market Forecast and Analysis
8.4. MACULAR DEGENERATION
8.4.1. Overview
8.4.2. Macular Degeneration Market Forecast and Analysis
8.5. DIABETIC MACULAR EDEMA
8.5.1. Overview
8.5.2. Diabetic Macular Edema Market Forecast and Analysis
8.6. RETINAL VEIN OCCLUSION
8.6.1. Overview
8.6.2. Retinal Vein Occlusion Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis

9. RETINAL DISORDER TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
9.1. OVERVIEW
9.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
9.3. HOSPITAL PHARMACY
9.3.1. Overview
9.3.2. Hospital Pharmacy Market Forecast and Analysis
9.4. ONLINE PHARMACY
9.4.1. Overview
9.4.2. Online Pharmacy Market Forecast and Analysis
9.5. RETAIL PHARMACY
9.5.1. Overview
9.5.2. Retail Pharmacy Market Forecast and Analysis

10. RETINAL DISORDER TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Retinal Disorder Treatment Market Overview
10.1.2 North America Retinal Disorder Treatment Market Forecasts and Analysis
10.1.3 North America Retinal Disorder Treatment Market Forecasts and Analysis - By Product Type
10.1.4 North America Retinal Disorder Treatment Market Forecasts and Analysis - By Disease Indication
10.1.5 North America Retinal Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.1.6 North America Retinal Disorder Treatment Market Forecasts and Analysis - By Countries
10.1.6.1 United States Retinal Disorder Treatment Market
10.1.6.1.1 United States Retinal Disorder Treatment Market by Product Type
10.1.6.1.2 United States Retinal Disorder Treatment Market by Disease Indication
10.1.6.1.3 United States Retinal Disorder Treatment Market by Distribution Channel
10.1.6.2 Canada Retinal Disorder Treatment Market
10.1.6.2.1 Canada Retinal Disorder Treatment Market by Product Type
10.1.6.2.2 Canada Retinal Disorder Treatment Market by Disease Indication
10.1.6.2.3 Canada Retinal Disorder Treatment Market by Distribution Channel
10.1.6.3 Mexico Retinal Disorder Treatment Market
10.1.6.3.1 Mexico Retinal Disorder Treatment Market by Product Type
10.1.6.3.2 Mexico Retinal Disorder Treatment Market by Disease Indication
10.1.6.3.3 Mexico Retinal Disorder Treatment Market by Distribution Channel
10.2. EUROPE
10.2.1 Europe Retinal Disorder Treatment Market Overview
10.2.2 Europe Retinal Disorder Treatment Market Forecasts and Analysis
10.2.3 Europe Retinal Disorder Treatment Market Forecasts and Analysis - By Product Type
10.2.4 Europe Retinal Disorder Treatment Market Forecasts and Analysis - By Disease Indication
10.2.5 Europe Retinal Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.2.6 Europe Retinal Disorder Treatment Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Retinal Disorder Treatment Market
10.2.6.1.1 Germany Retinal Disorder Treatment Market by Product Type
10.2.6.1.2 Germany Retinal Disorder Treatment Market by Disease Indication
10.2.6.1.3 Germany Retinal Disorder Treatment Market by Distribution Channel
10.2.6.2 France Retinal Disorder Treatment Market
10.2.6.2.1 France Retinal Disorder Treatment Market by Product Type
10.2.6.2.2 France Retinal Disorder Treatment Market by Disease Indication
10.2.6.2.3 France Retinal Disorder Treatment Market by Distribution Channel
10.2.6.3 Italy Retinal Disorder Treatment Market
10.2.6.3.1 Italy Retinal Disorder Treatment Market by Product Type
10.2.6.3.2 Italy Retinal Disorder Treatment Market by Disease Indication
10.2.6.3.3 Italy Retinal Disorder Treatment Market by Distribution Channel
10.2.6.4 Spain Retinal Disorder Treatment Market
10.2.6.4.1 Spain Retinal Disorder Treatment Market by Product Type
10.2.6.4.2 Spain Retinal Disorder Treatment Market by Disease Indication
10.2.6.4.3 Spain Retinal Disorder Treatment Market by Distribution Channel
10.2.6.5 United Kingdom Retinal Disorder Treatment Market
10.2.6.5.1 United Kingdom Retinal Disorder Treatment Market by Product Type
10.2.6.5.2 United Kingdom Retinal Disorder Treatment Market by Disease Indication
10.2.6.5.3 United Kingdom Retinal Disorder Treatment Market by Distribution Channel
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Retinal Disorder Treatment Market Overview
10.3.2 Asia-Pacific Retinal Disorder Treatment Market Forecasts and Analysis
10.3.3 Asia-Pacific Retinal Disorder Treatment Market Forecasts and Analysis - By Product Type
10.3.4 Asia-Pacific Retinal Disorder Treatment Market Forecasts and Analysis - By Disease Indication
10.3.5 Asia-Pacific Retinal Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.3.6 Asia-Pacific Retinal Disorder Treatment Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Retinal Disorder Treatment Market
10.3.6.1.1 Australia Retinal Disorder Treatment Market by Product Type
10.3.6.1.2 Australia Retinal Disorder Treatment Market by Disease Indication
10.3.6.1.3 Australia Retinal Disorder Treatment Market by Distribution Channel
10.3.6.2 China Retinal Disorder Treatment Market
10.3.6.2.1 China Retinal Disorder Treatment Market by Product Type
10.3.6.2.2 China Retinal Disorder Treatment Market by Disease Indication
10.3.6.2.3 China Retinal Disorder Treatment Market by Distribution Channel
10.3.6.3 India Retinal Disorder Treatment Market
10.3.6.3.1 India Retinal Disorder Treatment Market by Product Type
10.3.6.3.2 India Retinal Disorder Treatment Market by Disease Indication
10.3.6.3.3 India Retinal Disorder Treatment Market by Distribution Channel
10.3.6.4 Japan Retinal Disorder Treatment Market
10.3.6.4.1 Japan Retinal Disorder Treatment Market by Product Type
10.3.6.4.2 Japan Retinal Disorder Treatment Market by Disease Indication
10.3.6.4.3 Japan Retinal Disorder Treatment Market by Distribution Channel
10.3.6.5 South Korea Retinal Disorder Treatment Market
10.3.6.5.1 South Korea Retinal Disorder Treatment Market by Product Type
10.3.6.5.2 South Korea Retinal Disorder Treatment Market by Disease Indication
10.3.6.5.3 South Korea Retinal Disorder Treatment Market by Distribution Channel
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Retinal Disorder Treatment Market Overview
10.4.2 Middle East and Africa Retinal Disorder Treatment Market Forecasts and Analysis
10.4.3 Middle East and Africa Retinal Disorder Treatment Market Forecasts and Analysis - By Product Type
10.4.4 Middle East and Africa Retinal Disorder Treatment Market Forecasts and Analysis - By Disease Indication
10.4.5 Middle East and Africa Retinal Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.4.6 Middle East and Africa Retinal Disorder Treatment Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Retinal Disorder Treatment Market
10.4.6.1.1 South Africa Retinal Disorder Treatment Market by Product Type
10.4.6.1.2 South Africa Retinal Disorder Treatment Market by Disease Indication
10.4.6.1.3 South Africa Retinal Disorder Treatment Market by Distribution Channel
10.4.6.2 Saudi Arabia Retinal Disorder Treatment Market
10.4.6.2.1 Saudi Arabia Retinal Disorder Treatment Market by Product Type
10.4.6.2.2 Saudi Arabia Retinal Disorder Treatment Market by Disease Indication
10.4.6.2.3 Saudi Arabia Retinal Disorder Treatment Market by Distribution Channel
10.4.6.3 U.A.E Retinal Disorder Treatment Market
10.4.6.3.1 U.A.E Retinal Disorder Treatment Market by Product Type
10.4.6.3.2 U.A.E Retinal Disorder Treatment Market by Disease Indication
10.4.6.3.3 U.A.E Retinal Disorder Treatment Market by Distribution Channel
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Retinal Disorder Treatment Market Overview
10.5.2 South and Central America Retinal Disorder Treatment Market Forecasts and Analysis
10.5.3 South and Central America Retinal Disorder Treatment Market Forecasts and Analysis - By Product Type
10.5.4 South and Central America Retinal Disorder Treatment Market Forecasts and Analysis - By Disease Indication
10.5.5 South and Central America Retinal Disorder Treatment Market Forecasts and Analysis - By Distribution Channel
10.5.6 South and Central America Retinal Disorder Treatment Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Retinal Disorder Treatment Market
10.5.6.1.1 Brazil Retinal Disorder Treatment Market by Product Type
10.5.6.1.2 Brazil Retinal Disorder Treatment Market by Disease Indication
10.5.6.1.3 Brazil Retinal Disorder Treatment Market by Distribution Channel
10.5.6.2 Argentina Retinal Disorder Treatment Market
10.5.6.2.1 Argentina Retinal Disorder Treatment Market by Product Type
10.5.6.2.2 Argentina Retinal Disorder Treatment Market by Disease Indication
10.5.6.2.3 Argentina Retinal Disorder Treatment Market by Distribution Channel

11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

12. RETINAL DISORDER TREATMENT MARKET, KEY COMPANY PROFILES
12.1. NOVARTIS AG
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. SANTEN PHARMACEUTICAL CO., LTD.
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. REGENERON
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. GRAYBUG VISION, INC
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. BAYER AG
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. GENENTECH, INC.
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. ACUCELA INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. PFIZER, INC
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. OXURION NV.
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments

13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. NOVARTIS AG
2. SANTEN PHARMACEUTICAL CO., LTD.
3. REGENERON
4. GRAYBUG VISION, INC
5. SHIRE (TAKEDA PHARMACEUTICAL COMPANY LIMITED)
6. BAYER AG
7. GENENTECH, INC.
8. ACUCELA INC
9. PFIZER, INC
10. OXURION NV
TIPRE00006833
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking
Contact Us : +1-646-491-9876 | +91-20-67271633 | Email : sales@theinsightpartners.com
© Copyright 2021 - The Insight Partners. All rights reserved